Requests similar to 'Numbers and percentages'
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Please find attached a response to your request for information received
14 November 2020.
Please let us know if you requi...
All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors
Response by Pharmaceutical Management Agency to Stefan Clausing on .
Awaiting classification.
Kia ora Stefan,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pātaka W...
Meeting notes and outcomes
Response by Pharmaceutical Management Agency to A L.C on .
Awaiting classification.
Kia ora AL.C,
Please find attached the final part of your response, to your Official
Information Act request.
Please contact us if you hav...
Decision to delay Pump and CGM Funding for T1 Diabetics
Response by David Seymour to Fiona Smith on .
Awaiting classification.
Dear Fiona
Please find attached response to your OIA request of 29 May.
Kind regards, Annette
Annette Gratkowski | Private Secretary...
Public knowledge of communication
Response by Pharmaceutical Management Agency to A L.C on .
Successful.
Kia ora
Please find attached a response to your request for official information.
Ngā mihi
Government Services | Pharmac
______...
Numbers of prescriptions: Antidepressants Antipsychotics and ADHD medication/stimulants
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J Bruning
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Correspondence between Pharmac and NZMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Further to our email to you on 23 September 2021, please find our final
response with documents for your request attached with t...
Immunosuppressed/diabetic/cancer populations - common associated conditions.
Response by Pharmaceutical Management Agency to J Bruning on .
Information not held.
Kia ora Jodie,
Please find attached a response to your Official Information Act request of 17 April 2024.
Thank you
Government Services
_____________...
Information regarding medicinal cannabis prescriptions
Response by Pharmaceutical Management Agency to Mr McDonald on .
Information not held.
Kia ora Mr McDonald,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pāt...
Estimating the number of people prescribed PrEP
Response by Pharmaceutical Management Agency to Bianca Sepulveda on .
Successful.
Kia ora Bianca
Please find attached a response to your recent request for information.
Ngā mihi
Melody Willis ([1]she/her) | Gove...
Decision not to provide information to Today FM or Mediaworks
Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on .
Refused.
Tēnā koe
Further to our previous communications, we have now published
[1]information about our communications approach for the Trikafta
consul...
Cost of PreP since funding began in 2018
Response by Pharmaceutical Management Agency to Elliot Ikilei on .
Successful.
Kia ora Elliot
Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.
Please feel free to...
Maori Advisory Committee
Response by Pharmaceutical Management Agency to Alan Riley on .
Successful.
Kia ora Alan,
Please find attached a response to your Official Information Act request,
which was received on 13 November 2024.
Please con...
Communications regarding funding of Freestyle Libre monitors
Response by Pharmaceutical Management Agency to Harry Peterson on .
Awaiting classification.
Kia ora Harry,
Please see attached.
Arihia Gray [1](she/her) | Policy advisor
13 September 2022
Harry Peterson
[FOI #20235 email]
Tēn...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find a response for your request for information attached with this email.
Ngā mihi
Simon
Simon Mitchell | Senior Policy Adviso...
Shortage of prescribed medication Concerta
Response by Pharmaceutical Management Agency to gerald on .
Awaiting classification.
Kia ora Gerald
Apologies, the correct due date for your response is 4 June 2025.
Ngā mihi
Government Services | Pharmac
___________...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth,
Please find attached our response letter and the relevant documents
released to you under the Official Information Act.
...
Cancer drugs v other drugs
Response by Pharmaceutical Management Agency to Brendon Mills on .
Successful.
Kia ora Brendon
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
_...
Cost of funding Tramadol in 2019
Response by Pharmaceutical Management Agency to Brianna Stewart on .
Successful.
Kia ora Brianna
Please find the response to your OIA 2020-21-020 dated 18 August 2020
regarding tramadol funding for calendar year 2019.
N...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
Reappointment / Appointments to the Board of Pharmac – Te Pātaka Whaioranga
Response by Ministry of Health to john luke on .
Successful.
Kia ora John Luke
Please find attached a letter regarding your request for official
information. If you wish to discuss any aspe...
Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003
Response by Pharmaceutical Management Agency to Harris Leigh on .
Successful.
Tēnā koe Harris
Please find a response to your request for information attached with this
email.
Ngā mihi, nā
Melody Willis ([1]...
Why have you restricted Ivermectin?
Response by Pharmaceutical Management Agency to Annie Weston on .
Successful.
Mōrena Annie
Please find a response to your request about ivermectin attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Servic...
Kia ora Jayson,
We acknowledge receipt of your request on 14 June 2023.
We have forwarded this request to our Waste Managemnet Team in the...
COVID-19 Early Treatment Options - where are they?
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Can I please confirm your below question still relates specifically to people with COVID-19?
Ngā mihi
Melody Willis (she/her) | Gover...